IPO Issue Details
Issue Price / Price Band₹825 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size18 Shares per Lot
Total Issue Size2,59,95,042 shares (aggregating up to ₹2,143.74 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryFresh Capital-cum-Offer for Sale
Exchange / PlatformNSE & BSE
IPO TypeMainboard
Subscription OpenWed, 16 Jun 2021
Subscription CloseFri, 18 Jun 2021
Anchor AllotmentTue, 15 Jun 2021
Basis of AllotmentWed, 23 Jun 2021
Initiation of RefundsThu, 24 Jun 2021
Credit of Shares to DematFri, 25 Jun 2021
Listing DateMon, 28 Jun 2021
UPI Mandate Deadline2021-06-18
Application & Investment Details
Retail — Min (1 Lots)₹14,850 — 18 shares
Retail — Max (13 Lots)₹193,050 (13 Lots)
HNI — Min (14 Lots)₹2,07,900 — 252 shares
Pre-IPO Promoter Holding7,75,93,283 shares
Post-IPO Promoter Holding8,00,29,878 shares
Fresh Issue Shares24,36,399 shares (aggregating up to ₹200.92 Cr)
Offer for Sale Shares2,35,58,643 shares of ₹10 (aggregating up to ₹1,942.82 Cr)
About Krishna Institute of Medical Sciences Ltd.
Incorporated in 1973, Krishna Institute of Medical Sciences Limited (KIMS) is one of the largest healthcare groups in AP and Telangana. KIMS provides multi-disciplinary healthcare services with a key focus on primary, secondary, & tertiary care in tier 2-3 cities. The company offers a comprehensive range of healthcare services including oncology, cardiac sciences, neurosciences, gastric sciences, orthopaedics, renal sciences, organ transplantation, and mother & child care.As of March 31, 2021, it operates through 9 multi-speciality hospitals under the brand name of "KIMS Hospitals" with an aggregate bed capacity of 3,064 under the "KIMS Hospitals" brand, with an aggregate bed capacity of 3,064 including over 2,500 operational beds.Competitive strengthsOne of the largest corporate healthcare service provider in AP and Telangana.Highly qualified and trained doctors and medical support staff.Strong operational and financial performance.Experienced managerial team.
Objects of the Issue
Krishna Institute of Medical Sciences Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
1
1 Repayment/pre-payment, in full or part, of certain borrowings availedby our Companyand by ourSubsidiaries vizKHKPL, SIMSPL and KHEPL
150.00
2
2 General corporate purposes
41.66
Shareholding & Lock-in
Pre-IPO Promoter Holding
7,75,93,283 shares
Post-IPO Promoter Holding
8,00,29,878 shares
Lock-in Period (30%)July 23, 2021
Lock-in Period (50%)September 21, 2021